GOLDCREST Co.,Ltd.
CDCTFOTCReal Estate● Active
$20.55
+$0.00(+0.00%)
Market Cap$682980421
P/E Ratio—
52W High$25.43
52W Low$12.72
GOLDCREST Co.,Ltd. (CDCTF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CDCTF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
$0.21
Est. $0.11 · +101.0%
Revenue
$0.05B
Est. $0.05B · +3.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 10-Quarter EPS Beat Streak
CDCTF reports quarterly as a OTC-listed Real Estate - Development company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.02
Rev. $0.33B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.02
Rev. Est.$0.33B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 23, 2026 | $0.79 | — | — | — | $0.09B | — |
| ▲ Q2 FY2026 | May 14, 2026 | $0.11 | $0.21 | +101.0% | $0.05B | $0.05B | +3.4% |
| ▲ Q1 FY2026 | Jan 30, 2026 | $0.13 | $0.24 | +82.7% | $0.04B | $0.04B | +18.7% |
| ▲ Q4 FY2025 | Oct 29, 2025 | $0.13 | $29.55 | +22084.7% | $0.04B | $0.04B | -15.1% |
| ▲ Q3 FY2025 | Jul 29, 2025 | $0.23 | $0.52 | +126.0% | $0.07B | $0.04B | +84.8% |
| ▲ Q2 FY2025 | May 14, 2025 | -$0.04 | $0.08 | +318.6% | $0.03B | $0.03B | +7.2% |
| ▲ Q1 FY2025 | Jan 31, 2025 | $0.20 | $0.43 | +115.6% | $0.07B | $0.06B | +15.0% |
| ▲ Q4 FY2024 | Oct 31, 2024 | $0.15 | $0.24 | +58.8% | $0.05B | $0.03B | +37.3% |
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
$0.79
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
$0.21
EPS Est.
$0.11
EPS Surpr.
+101.0%
Revenue
$0.05B
Q1 FY2026
Jan 30, 2026Beat
EPS Actual
$0.24
EPS Est.
$0.13
EPS Surpr.
+82.7%
Revenue
$0.04B
Q4 FY2025
Oct 29, 2025Beat
EPS Actual
$29.55
EPS Est.
$0.13
EPS Surpr.
+22084.7%
Revenue
$0.04B
Q3 FY2025
Jul 29, 2025Beat
EPS Actual
$0.52
EPS Est.
$0.23
EPS Surpr.
+126.0%
Revenue
$0.07B
Q2 FY2025
May 14, 2025Beat
EPS Actual
$0.08
EPS Est.
-$0.04
EPS Surpr.
+318.6%
Revenue
$0.03B
Q1 FY2025
Jan 31, 2025Beat
EPS Actual
$0.43
EPS Est.
$0.20
EPS Surpr.
+115.6%
Revenue
$0.07B
Q4 FY2024
Oct 31, 2024Beat
EPS Actual
$0.24
EPS Est.
$0.15
EPS Surpr.
+58.8%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $22.29 | $27.76 | $33.22 | 1 |
| Q4 FY2026 | $101.93 | $126.90 | $151.88 | 1 |
| Q3 FY2026 | $3.05 | $3.79 | $4.54 | 1 |
| Q2 FY2026 | $101.93 | $126.90 | $151.88 | 1 |
| Q1 FY2026 | $13.58 | $16.91 | $20.23 | 1 |
| Q4 FY2025 | $20.76 | $20.82 | $20.88 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $7.0B | $8.3B | $9.5B | 1 |
| Q4 FY2026 | $10.1B | $12.0B | $13.8B | 1 |
| Q3 FY2026 | $4.5B | $7.0B | $9.6B | 2 |
| Q2 FY2026 | $14.0B | $14.7B | $15.5B | 2 |
| Q1 FY2026 | $6.2B | $7.3B | $8.4B | 1 |
| Q4 FY2025 | $5.4B | $5.8B | $6.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +101.0% | $20.55 | $20.55 | +0.00% |
| ▲ Q1 FY2026 | Jan 30, 2026 | +82.7% | $20.55 | $20.55 | +0.00% |
| ▲ Q4 FY2025 | Oct 29, 2025 | +22084.7% | $20.55 | $20.55 | +0.00% |
| ▲ Q3 FY2025 | Jul 29, 2025 | +126.0% | $12.72 | $12.72 | +0.00% |
| ▲ Q2 FY2025 | May 14, 2025 | +318.6% | $12.72 | $12.72 | +0.00% |
| ▲ Q1 FY2025 | Jan 31, 2025 | +115.6% | $12.72 | $12.72 | +0.00% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +58.8% | $12.72 | $12.72 | +0.00% |
| — Q3 FY2024 | Jul 31, 2024 | — | $12.72 | $12.72 | +0.00% |
Q2 FY2026+0.00%
Report Date
May 14, 2026
EPS Beat/Miss
+101.0%
Price Before
$20.55
Price After
$20.55
Q1 FY2026+0.00%
Report Date
Jan 30, 2026
EPS Beat/Miss
+82.7%
Price Before
$20.55
Price After
$20.55
Q4 FY2025+0.00%
Report Date
Oct 29, 2025
EPS Beat/Miss
+22084.7%
Price Before
$20.55
Price After
$20.55
Q3 FY2025+0.00%
Report Date
Jul 29, 2025
EPS Beat/Miss
+126.0%
Price Before
$12.72
Price After
$12.72
Q2 FY2025+0.00%
Report Date
May 14, 2025
EPS Beat/Miss
+318.6%
Price Before
$12.72
Price After
$12.72
Q1 FY2025+0.00%
Report Date
Jan 31, 2025
EPS Beat/Miss
+115.6%
Price Before
$12.72
Price After
$12.72
Q4 FY2024+0.00%
Report Date
Oct 31, 2024
EPS Beat/Miss
+58.8%
Price Before
$12.72
Price After
$12.72
Q3 FY2024+0.00%
Report Date
Jul 31, 2024
EPS Beat/Miss
—
Price Before
$12.72
Price After
$12.72
Avg Beat Reaction+0.00%
Beat Rate7 / 8 quarters
Largest Move+0.00% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CDCTF ends December
GOLDCREST Co.,Ltd. (CDCTF) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $0.21 — beating the analyst consensus of $0.11 by +101.0%. CDCTF has beaten EPS estimates for 10 consecutive quarters. The next CDCTF earnings date is expected around September 1, 2026.
Each quarter, investors track CDCTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CDCTF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CDCTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CDCTF earnings · 5 questionsGOLDCREST Co.,Ltd.'s next earnings report is expected around September 1, 2026. CDCTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CDCTF historically reports after market close (AMC).
CDCTF earnings datewhen is CDCTF earningsCDCTF next earnings datewhen does CDCTF report earningsCDCTF earnings calendar
▸ Source: FMP · GOLDCREST Co.,Ltd. SEC filings · US GAAP · GOLDCREST Co.,Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026